Pharmaceutical Drugs

commentary

Ten Things That Inspired Me in 2022

It would be impossible to capture all the important work that RAND does in a year. But RAND president and CEO Jason Matheny has compiled ten times he was inspired by RAND's efforts to bring insight to some of the biggest policy stories of 2022.

Jason Matheny @JasonGMatheny

commentary

Medicare Drug Price Negotiation: Key Decisions to Reach a 'Fair Price'

Government negotiation of Medicare drug prices—even for a small set of older, single-source drugs—is a remarkable policy development. But how exactly will the government do it?

Andrew W. Mulcahy @AndrewWMulcahy

commentary

Improving How Medicines R&D Is Financed Could Support Innovation and Benefits for Patients

Tackling chronic and infectious diseases depends to a large extent on the ability to develop innovative and affordable medicines that are available to patients in need. Policymakers will need to tackle challenges from multiple angles to avoid reducing barriers in one area at the expense of exacerbating challenges in another.

Sarah Parkinson, Sonja Marjanovic @SonjaCambs

blog

State of the Union 2022: Russia's Invasion of Ukraine and Domestic Policy

In his first State of the Union address, President Joe Biden rebuked Russia for its invasion of Ukraine, aimed to turn a page on the pandemic, and covered a wide range of domestic issues, including mental health care, prescription drug prices, and supporting veterans.

blog

Geoengineering, the Russia-Ukraine Crisis, Biosimilar Drugs: RAND Weekly Recap

This weekly recap focuses on technologies that manipulate the climate, what NATO could do to address the Ukraine-Russia crisis, and cost savings from biosimilar drugs.

blog

The Most Popular RAND Research of 2021

As another extraordinary year draws to a close, we continue to believe that objective, nonpartisan research and analysis has a key role to play in navigating what continues to be a difficult time. Here are the 10 research projects that resonated most with rand.org readers in 2021.

blog

Gender Pay Gap Among Doctors, America's Labor Shortage, 'Hacking Equity': RAND Weekly Recap

This weekly recap focuses on the pay gap between female and male doctors, understanding America’s weird job market, social and emotional learning, and more.

commentary

What Are the Practical Considerations for Outcome-Based Payment in the NHS?

Uncertainty can surround the effectiveness or cost-effectiveness of a new medicine, making it difficult to agree on a medicine's price. One solution to avoid unduly delaying or restricting patients' access is to link the medicine's price to the outcomes it produces in a patient. Despite some barriers, outcome-based payment could offer a “win” for patients, the NHS, and industry.

Amanda Cole, Jon Sussex

commentary

Malaria Vaccine May Not Eliminate Need to Combat Counterfeit Medicines

The newly announced malaria vaccine could be a critical tool to combat the tremendous socioeconomic burden malaria causes. But global achievements in reducing malaria cases and deaths in the past decades may be in danger of significant reversal if the problem of counterfeiting continues.

Samantha McBirney, Krishna B. Kumar @kbkumar_, et al.

blog

'GDP2,' RAND President and CEO to Retire, Quantum Technology: RAND Weekly Recap

This weekly recap focuses on why we should measure ‘GDP2,’ an announcement from RAND president and CEO Michael D. Rich, a look at quantum technology, and more.

blog

Prescription Drug Prices, Unemployment Insurance, Anti-Asian Racism: RAND Weekly Recap

This weekly recap focuses on lowering prescription drug prices, reforming unemployment insurance, addressing anti-Asian racism, and more.

blog

President Biden's First Address to Congress: Insights from RAND

President Joe Biden addressed a joint session of Congress, summarizing his administration's early COVID-19 response and outlining plans that aim to loosen the pandemic's year-long grip on a weary nation. The speech reflected the fact that the United States faces policy challenges across a wide range of domains.

blog

Prescription Drug Prices, Transgender Troops, Space Diplomacy: RAND Weekly Recap

This weekly recap focuses on America's high prescription drug prices, allowing transgender troops in the military, food insecurity in Black neighborhoods, and more.

blog

A Message from Our President, Medical Mistrust, Insulin Prices: RAND Weekly Recap

This weekly recap focuses on Wednesday’s siege on the U.S. Capitol, Americans' psychological distress, medical mistrust and COVID-19 vaccines, and more.

essay

The Astronomical Price of Insulin Hurts American Families

More than 30 million Americans have diabetes, and nearly a quarter of them use insulin to manage their symptoms and prevent life-threatening complications. The price they have to pay for insulin is more than ten times higher than the average prices in 32 other countries combined.